Axcelis Technologies, Inc. (NASDAQ:ACLS) Stock Has Average Price Target of $148.67 According to Analysts

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have been assigned an average rating of “Hold” from the five research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $148.67.

ACLS has been the topic of several recent research reports. Bank of America lifted their target price on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a report on Tuesday, June 23rd. Craig Hallum cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price target for the company. in a research note on Friday, August 7th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a research note on Friday, August 7th.

Institutional Trading of Axcelis Technologies

Several institutional investors have recently added to or reduced their stakes in the stock. Central Pacific Bank Trust Division increased its position in Axcelis Technologies by 47.9% during the 3rd quarter. Central Pacific Bank Trust Division now owns 5,567 shares of the semiconductor company’s stock valued at $730,000 after purchasing an additional 1,802 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in shares of Axcelis Technologies by 25.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 598 shares of the semiconductor company’s stock worth $78,000 after purchasing an additional 123 shares during the period. Cim Investment Management Inc. acquired a new position in shares of Axcelis Technologies in the 2nd quarter worth approximately $301,000. QRG Capital Management Inc. boosted its stake in shares of Axcelis Technologies by 6.9% in the 2nd quarter. QRG Capital Management Inc. now owns 10,254 shares of the semiconductor company’s stock valued at $1,942,000 after purchasing an additional 658 shares during the last quarter. Finally, Sequoia Financial Advisors LLC bought a new stake in shares of Axcelis Technologies in the 2nd quarter valued at $367,000. 89.98% of the stock is currently owned by institutional investors.

Axcelis Technologies Trading Down 1.9%

ACLS opened at $138.40 on Monday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.90 and a quick ratio of 3.21. Axcelis Technologies has a fifty-two week low of $73.60 and a fifty-two week high of $193.78. The company’s 50 day moving average price is $124.83 and its two-hundred day moving average price is $135.60. The firm has a market capitalization of $4.27 billion, a price-to-earnings ratio of 46.44, a PEG ratio of 4.31 and a beta of 1.86.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The company had revenue of $215.18 million for the quarter, compared to analyst estimates of $205.03 million. During the same quarter in the previous year, the business earned $1.13 earnings per share. Axcelis Technologies’s revenue was up 10.6% compared to the same quarter last year. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. As a group, research analysts predict that Axcelis Technologies will post 3.39 earnings per share for the current year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc (NASDAQ: ACLS) develops and manufactures equipment used in semiconductor fabrication. The company’s primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.